Search

everythinglearnresearchcommunity

for

Search:↓

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Researchers found a genetic region that influences the number of coat layers in dogs.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Iron deficiency might contribute to hair loss in women.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.